Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cash payments tested as tool to fight HIV disparities in the south

NCT ID NCT06186128

Disease control Sponsor: University of Arkansas Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving low-income Black men living with HIV a universal basic income of $500 per month for six months helps them get regular HIV care and stick with their medication. Researchers in Arkansas will compare 80 men who receive the payments to those who don't, tracking clinic visits and viral suppression. The goal is to see if reducing financial stress can improve health outcomes and address racial inequities in HIV care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Universal Basic Income (cash payments of $500 per month for 6 months)
What this could lead to
If it works, this could show that providing regular cash payments helps low-income Black men with HIV stay in care and achieve viral suppression.
What could go wrong
This is a small, early-stage study with only 80 participants in one region, so results may not apply broadly. The cash payments are short-term, and lasting benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 years and older

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. be at least 25 years old; 2. self-report as having received from a medical professional a diagnosis for HIV; 3. have an annual income up to 400% of the federal poverty threshold (the 2023 federal poverty threshold is defined as an annual income of less than $14,580 for single adults) in the 12-month period prior to study enrollment; 4. be able to understand and speak English and to provide written and verbal informed consent; 5. plan to remain in the central Arkansas area for the duration of the study period; 6. be willing and able to provide weekly information about all activities related to seeking employment and to share financial and income-related information with the study team; 7. self-identify as Black or African American; 8. have been assigned the male gender at birth; 9. be willing to provide medical releases to allow project staff to access healthcare records, and 10. in need of HIV care services (defined as having a detectable viral load meaning \>200 copies/mL on most recent viral load test or not having attended a HIV medical care visit in the past 6 months, excluding any visits to the emergency department or rooms or urgent care clinics) Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health care utilization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease Patient Acceptance of Health Care

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health care utilization HIV

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Arkansas for Medical Sciences

    RECRUITING

    Little Rock, Arkansas, 72204, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.